9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients Transpl Infect Dis 2010
2. 2010 Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation. A randomized, controlled trial Ann Intern Med 2010; 152:761-769. (note: Davis and Avery are co-senior authors).
3. 2010 A 21-year-old man with Still’s disease with fever, rash, and pancytopenia. Arthritis Care Res (Hoboken) 2010; 62:575-9.
4. 2010 Utility of leflunomide in the treatment of complex CMV syndromes Transplantation 2010
5. 2010 Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group Transpl Infect Dis 2010; 12:190-194.
6. 2010 infectious disease following kidney transplantation: Core Curriculum 2010 Am J Kidney Dis 2010; 55(4): 755-771
7. 2010 Reply to Hage et al (letter). Clin Infect Dis 2010; 50:123-4
8. 2009 Screening of donor and recipient prior to solid organ transplantation Am J Transplant 2009; 9 Suppl 4: S7-18.
9. 2009 Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49:710-6
10. 2009 Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients Liver Transpl 2009; 15: 1557-63
11. 2009 Near-total human face transplantation for a severely disfigured patient in the USA Lancet 2009 Jul 18; 374:203-9
12. 2009 Aspergillosis in hematopoietic stem cell transplant recipients: risk factors, prophylaxis, and treatment Curr Infect Dis Rep 2009 May; 11:223-8.
13. 2009 Strategies for safe living following solid organ transplantation. Am J Transplant 2009; 9 Suppl 4; S252-7.
14. 2008 Classic concepts and modern developments in transplant infectious disease: the work of Robert H. Rubin Curr Opin Organ Transplant 2008 (Dec): 13:601-3
15. 2008 Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients Transpl Infect Dis 2008 Dec; 10:403-8
16. 2008 Update in management of ganciclovir-resistant cytomegalovirus infection. Curr Opinion Infect Dis 2008; 21:433-7
17. 2008 Update on immunizations in solid organ transplant recipients: what clinicians need to know American Journal of Transplantation 2008; 8:9-14.
18. 2007 Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus Clinical Infectious Diseases 2007; 45:448-9.
19. 2007 Valganciclovir vs. IV ganciclovir for therapy of cytomegalovirus viremia: has victory been achieved? American Journal of Transplantation 2007; 7: 2062-3.
20. 2007 Second look at leflunomide “failure” to control cytomegalovirus infection in the setting of renal failure Transpl Infect Dis 2007; 9: 260, author reply 260-1.
21. 2007 Endobronchial fungal disease: an under-recognized entity Respiration 2007; 74:88-104
22. 2007 Scedosporium apiospermum (Pseudallescheria boydii) infections in lung transplant recipients J Heart Lung Transplant 2007; 26:350-6
23. 2007 Management of Fever and Neutropenia in Leukemia Clinical Malignant Hematology, eds. Sekeres MA, Kalaycio ME, Bolwell BJ, McGraw-Hill 2007. Chapter 34, pp 311-320
24. 2007 Approach to the Immunocompromised Patient Hospital Medicine Secrets, ed. Glasheen JJ (assoc editor Amir Jaffer) Mosby/Elsevier 2007. Chapter 53, pp. 350-354.
25. 2007 Infections after kidney transplantation. Kidney Transplantation: State of the Art, second edition, ed Donald E. Hricik. Remedica 2007, London, UK and Chicago, US, pp 139-164
26. 2007 Management of late, recurrent, and resistant cytomegalovirus in transplant patients Transplantation Reviews 2007; 21: 65-76
27. 2007 Strategies for infection prevention after kidney transplantation. Current Opinion in Organ Transplantation 2007; 12:362-370.
28. 2006 Infections after lung transplantation Lung Transplantation: Evolving Concepts and Controversies; Guest Editor, Scott M. Palmer. Semin Resp Crit Care Med 2006; 27:544-551.
29. 2006 Fluoroquinolone resistance in Ureaplasma parvum in the United States J Clin Microbiol (2006 Apr) 44(4):1590-1.
30. 2006 Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant (2006 Mar) 25(3):294-7
31. 2006 A young man with a cough, an abnormal chest radiograph, and multiple skin lesions. Cleve Clin J Med (2006 Mar) 73(3):273-80
32. 2006 The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation J Heart Lung Transplant 2006; 25:820-824.
33. 2006 Can donors with prior hepatitis be safely used for heart transplantation? J Heart Lung Transplant 2006; 25:805-813
34. 2005 Commentary: relevance of waning measles immunity after HSCT Contagion 2005; 2:225-227
35. 2005 Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia Mayo Clin Proc (2005 Sep) 80(9):1215-6
36. 2005 The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study. J Heart Lung Transplant (2005 Nov) 24(11):1766-9
37. 2005 Fatal West Nile Virus infection after rituximab/fludarabine—induced remission for non-Hodgkin's lymphoma Clin Lymphoma Myeloma (2005 Nov) 6(3):248-50.
38. 2005 Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection Bone Marrow Transplant 2005; 35:375-81
39. 2005 Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients Am J Transplant 2005; 5:544-8
40. 2005 Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course Bone Marrow Transplant 2005; 35:497-9
41. 2005 BK virus and renal dysfunction: not limited to kidney transplantation? Clin Infect Dis (2005 Dec 15) 41(12):1726-7
42. 2005 Use of anti-HCV-positive organs Am J Transplant 2005; 5:1579
43. 2004 Adding Gram-positive prophylaxis to fluoroquinolone regimens reduces streptococcal bacteraemias, but prophylaxis remains controversial. Journal of Clinical Oncology 2003; 21: 4127-4137.) Cancer Treat Rev 2004; 30:385-8.
44. 2004 Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 2004; 23: 277-83.
45. 2004 Neuralgic amyotrophy precipitated by Epstein-Barr virus. Neurology 2004; 62:1234-5.
46. 2004 Encephalitis due to human herpesvirus-6 after cardiac transplant – a case report. Am J Transplant, 2004; 4:1200-3.
47. 2004 Correlation between blood and bronchoalveolar lavage CMV viral load with histology and CMV immunochemistry in lung transplant recipients J Clin Microbiol 2004; 42; 2168-72.
48. 2004 Guidelines for the Prevention and Management of Infectious Complications of Solid Organ Transplantation Am J Transplant 2004; Suppl 10: 5-166.
49. 2004 Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection Bone Marrow Transplant 2004; 34:1071-5.
50. 2004 Prophylactic strategies before organ transplantation Curr Opinion Infect Dis 2004; 17:353-6.
51. 2003 Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients Clin Infect Dis 2003; 36:46-52
52. 2003 Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant Infect Dis 2003; 36:1503-4, author reply 1504
53. 2003 Cardiac-allograft vasculopathy N Engl J Med 2003; 349:829-30.
54. 2003 Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients:  a case based review Transplant Infectious Disease 2003; 5:98-103
55. 2003 Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi Clin Infect Dis 2003; 37:221-9
56. 2002 The relationship between cytomegalovirus and chronic allograft dysfunction.  Transplantation Clinical Management Module Vol. 7, Medscape Transplantation
57. 2002 The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high dose etoposide (VP-16) for stem cell mobilization Bone Marrow Transplant 2002; 30: 311-4
58. 2002 Recipient screening prior to solid-organ transplantation Clinical Infectious Diseases 2002; 35: 1513-9. 
59. 2002 A case of zygomycosis and invasive candidiasis invloving the epiglottis and tongue in an immunocopromised patient.  Scand J Infect Dis.  2002; 34 (2): 149-51
60. 2002 Transplant recipients and the threat of bioterrorism AST Newsletter 2002; 1(5): 1-3
61. 2002 The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants Transpl Infect Dis 2002; 4:195-200.
62. 2002 Adult immunization and antibiotic prophylaxis guidelines Disease Management Project, 2002.
63. 2002 Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant receipients J Infect Dis 2002; 186: 760-8
64. 2002 Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection Transpl Infect Dis 2002; 4:189-194. 
65. 2002 Pneumonia in the immunocompromised host Current Treatment Options in Infectious Disease 2002; 4(3): 249-266
66. 2001 Immigrant women’s health: Infectious diseases - Part 2 West J Med 2001; 175:277-9
67. 2001 Immunizations in adult immunocompromised patients: Which to use and which to avoid.  Cleveland Clinic Journal of Medicine 2001; 68:337-48
68. 2001 Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection.  Journal Heart Lung Transplant   2001 20(4): 425-30
69. 2001 Hypogammaglobulinemia after heart transplantation: impact of preemptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes.  Transplant Infectious Disease 2001; 3 Suppl 2:40-3. 
70. 2001 Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation.  Bone Marrow Transplant 2001 Sep; 28 (5): 491-5.
71. 2001 Prophylactic measures in the solid-organ recipient before transplantation Clinical Infectious Disease (2001 July 1) 33 Suppl 1: S15-21
72. 2001 Immigrant women’s health: Infectious diseases - Part 1.  Clinical assessment, tuberculosis, hepatitis, and malaria West J Med 2001; 175:208-11
73. 2001 Hepatitis A vaccine in liver transplant recipients Clin Infect Dis  2001; 32 (11): 1656-7
74. 2001 Viral triggers of cardiac-allograft dysfunction N Engl J Med 2001; 344 (20): 1545-7.
75. 2001 Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transplant Infectious Disease 2001; 3 (3): 161-7. 
76. 2001 Fungal infections in the organ transplant recipient Curr Opinion Organ Transplant 2001; 6:284-289.
77. 2000 High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients Bone Marrow Transplantation 2000; 25:67-9
78. 2000 Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis Transplant Infectious Disease 2000; 3 (2) 112-117
79. 2000 The use of combination cytomegalovirus immune globulin (CMVIG) plus ganciclovir for prophylaxis in CMV seronegative liver transplant recipients of a CMV seropositive donor organ: a  multicenter, open-label study Transplant Proc 2000; 33:2571-5.  
80. 2000 Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient. Scand J Infect Dis 2000; 32:94-96
81. 2000 A survey of CMV prophylaxis strategies among bone marrow transplant programs in the United States Bone Marrow Transplant 2000; 26:763-7
82. 2000 Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?  Transplant Infectious Disease 2000; 2:133-139.
83. 1999 Evolving concepts in the management of patients with neutropenia and fever.  Cleve Clin J Med 1999; 66:173-80.
84. 1999 Isolated primary hepatic lymphoma in a patient with acquired immunodeficiency syndrome International Journal of Infectious Diseases, 1999 Vol 4 Number 1: 57-58. 
85. 1999 Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999;28:240-246. 
86. 1999 Prevention of cytomegalovirus disease in allogeneic bone marrow transplant recipients Current Controversies in Bone Marrow Transplantation, ed. Brian Bolwell, Humana Press,
87. 1999 Immunogenicity of hepatitis A vaccine in decompensated liver disease Am J Gastroenterol 1999; 94:1601-4
88. 1999 Solid organ transplant-related infectious disease for the home care clinician.  Home Health Care Consultant 1999; 6:29-39
89. 1999 Special considerations regarding CMV in lung transplantation Transplant Infectious Disease 1999; Suppl, 1:13-18
90. 1999 Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipient Transplant Infectious Disease 1999 Dec;1(4):284-287
91. 1999 Vaccination of the immunosuppressed adult patient with rheumatologic disease. General Medical Care of the Patient with Rheumatic Disease, eds. Brian Mandell and Michael J. Baime, Rheumatic Disease Clinics of North America, 1999, 25:567-584.
92. 1999 Monitoring of CMV infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture Transplant Proc 1999; 31:1255-7
93. 1998 Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact, cost analysis, and review Clin Infect Dis 1998; 28:240-6. 
94. 1998 Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients Curr Opinion Cardiol 1998; 13;122-129
95. 1998 Infectious disease and transplantation: messages for the generalist Cleve Clin J Med 1998; 65:305-14. 
96. 1998 A randomized prospective controlled trial of oral acyclovir vs. oral ganciclovir for CMV prophylaxis in high risk kidney transplant recipients Transplantation 1998; 66:1682-8
97. 1998 Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients Clin Infect Dis 1998; 26:753-5
98. 1998 Chlamydial disease Principles and Practice of Ophthalmology, Second Edition, Chapter 250, WB Saunders
99. 1997 Significance of positive cultures from donor left atrium and postpreservation fluid in heart transplantation.  Transplantation 1997; 64:1209-10
100. 1997 Life after 20 years with a kidney transplant: redefined disease profiles and an emerging nondiabetic vasculopathy.  Transplant Proc 1997;29:247-249
101. 1997 Approach to the adult patient with recurrent infections Cleveland Clinic J Med 1997, 64(5):249-257.
102. 1996 Bilateral otitis media and  mastoiditis caused by a highly resistant strain of Mycobacterium chelonae Pediatric Infectious Disease Journal 1996 Nov;15(11):1037-1040
103. 1996 Cytomegalovirus infection in seromismatched lung transplant  recipients with and without prophylaxis with CMV immunoglobulin Transplant Proc 1996 Dec;28(6 Suppl 2):16.
104. 1996 Respiratory dimorphic fungal infections Topics in Clinical Dermatology, ed. Boni E. Elewski
105. 1996 The spectrum of orbital   aspergillosis.  Survey of Ophthalmology, 1996, 41:142-54
106. 1996 Serous retinal   detachments in a patient with clinically resistant cytomegalovirus retinitis Archives  of Opthalmology.  1996 July;114(7):896-897. 
107. 1995 Viral pulmonary infections in thoracic and cardiovascular surgery.  Semin Thorac Cardiovasc Surg 1995;7:88-94
108. 1995 Rhinoscleroma treated with ciprofloxacin: a case report.  The Laryngoscope, 105:1-3, July 1995
109. 1995 Transmission of Toxoplasma gondii infection by liver transplantation.  Clin Infect Dis 21:511-5, 1995
110. 1995 Inhibition  of cytotoxic T lymphocyte-triggered apoptosis by target cell surface-coupled  aprotinin Mol Immunol 1995, 32(12):853-864
111. 1994 Chlamydial infection Principles and Practice of Ophthalmology, eds. Daniel M. Albert and Frederick A. Jakobiec, W.B. Saunders
112. 1994 Infections and immunizations in organ transplant recipients: a preventive approach. Cleveland Clinic J Med 1994;61(5):386-392
113. 1994 Mycoplasma hominis wound infection Infect Dis Clin Pract,1994;3(1):32-34
114. 1992 Differences between ATP-mediated cytotoxicity and cell-mediated cytotoxicity J Immunol, August, 1992
115. 1992 Human Immunodeficiency Virus and Homeless Persons.  Delivering Health Care to Homeless Persons, eds. David Wood
116. 1991 AIDS and HIV Infection The Manual of Common Communicable Diseases in Shelters, eds.  James J. O'Connell and Janet Groth, Boston Health Care for the Homeless Program
117. 1990 Homelessness and AIDS Under the Safety Net:  The Health and Social Welfare of the Homeless in the United States, eds. P.W. Brickner et al, W.W. Norton, New York/London


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.